,sentence,pubmed_id,content,label,labeler
0,10 |||  ||| 0.10 ||| Seventy-eight patients with acute myocardial infarction according to World Health Organization criteria and within 12 hours of the onset of continuous chest pain were enrolled into the present study and underwent emergency angiography or angioplasty from November 2002 to May 2003.,15219514,Seventy-eight patients,po.Size,lingtaiwei
1,10 |||  ||| 0.10 ||| Seventy-eight patients with acute myocardial infarction according to World Health Organization criteria and within 12 hours of the onset of continuous chest pain were enrolled into the present study and underwent emergency angiography or angioplasty from November 2002 to May 2003.,15219514,within 12 hours of the onset of continuous chest pain,po.PhyConditon,lingtaiwei
2,10 |||  ||| 0.10 ||| Seventy-eight patients with acute myocardial infarction according to World Health Organization criteria and within 12 hours of the onset of continuous chest pain were enrolled into the present study and underwent emergency angiography or angioplasty from November 2002 to May 2003.,15219514,with acute myocardial infarction,po.Disease,lingtaiwei
3,"15 |||  ||| 0.15 ||| Inclusion criteria for BMSC implantation included age Ͻ70 years old, no cardiac shock or cardiac block, stable hemodynamics, and no severe co-morbidities.",15219514,age Ͻ70 years old,po.Age,lingtaiwei
4,"15 |||  ||| 0.15 ||| Inclusion criteria for BMSC implantation included age Ͻ70 years old, no cardiac shock or cardiac block, stable hemodynamics, and no severe co-morbidities.",15219514,"no cardiac shock or cardiac block, stable hemodynamics, and no severe co-morbidities.",po.Disease,lingtaiwei
5,1 |||  ||| 0.1 ||| Sixty-nine patients who underwent primary percuta-neous coronary intervention within 12 hours after onset of acute myocardial infarction were random-ized to receive intracoronary injection of autologous bone marrow mesenchymal stem cell or standard saline.,15219514,were random-ized to receive intracoronary injection of autologous bone marrow mesenchymal stem cell or standard saline.,i.Procedure,lingtaiwei
6,"16 |||  ||| 0.16 ||| Sixty-nine of 78 patients were candidates for the BMSC procedure and were randomized to receive BMSCs (n ϭ 34) or saline (PCI-only group, n ϭ 35) as the control arm.",15219514,"were randomized to receive BMSCs (n ϭ 34) or saline (PCI-only group, n ϭ 35) as the control arm.",i.Procedure,lingtaiwei
7,"88 |||  ||| 0.88 ||| Serial cardiac echocardiographic monitoring demonstrated improvement of cardiac function 1 to 3 months after implantation of BMSCs, and improvement was maintained nearly 6 months after the procedure.",15219514,"improvement of cardiac function 1 to 3 months after implantation of BMSCs, and improvement was maintained nearly 6 months after the procedure.",o.Treatment,lingtaiwei
8,"61 |||  ||| 0.61 ||| Perfusion defects decreased from 36.2 Ϯ 6.2% to 20.3 Ϯ 5.31%, and cardiac functional indexes also showed significant improvement (Table 4).",15219514,"Perfusion defects decreased from 36.2 Ϯ 6.2% to 20.3 Ϯ 5.31%, and cardiac functional indexes also showed significant improvement",o.Treatment,lingtaiwei
